Federal Judge Denies E-Cigarette Distributor's Summary Judgment Request

Regulations by 2FIRSTS.ai
Jan.11.2024
Federal Judge Denies E-Cigarette Distributor's Summary Judgment Request
Alabama federal judge denies e-cigarette distributor's motion claiming unpaid invoices, orders trial to determine validity.

A federal judge in Alabama has rejected a motion for a summary judgment made by an e-cigarette distributor, who claimed that a wholesaler owed them over $100,000 for unpaid product invoices, as reported by Law360 on January 10th.

 

In a brief order, Judge Annemarie Carney Axon stated that Safa Goods LLC failed to provide undisputed evidence to support its claim against Perfect Wholesale Inc., and therefore the trial must proceed.

 

According to the directive, there are currently some controversial issues, including whether the invoice constitutes a valid contract, whether Safa has fulfilled the contract, whether Perfect Wholesale has indeed accepted the goods, and whether the price has been determined in the contract.

 

Akson did not further elaborate on the reasons for her refusal to support the motion.

 

Safa filed a lawsuit against Perfect Wholesale in August, alleging that the wholesaler had shipped goods to them between October and December 2021. As of the last shipment, Perfect Wholesale owed $158,745 in outstanding payments.

 

According to the lawsuit, Safa extended a credit of $55,200 to Perfect Wholesale in February 2022. As of that time, the wholesaler still owed $103,545 and had failed to make payment in response to a letter demanding payment.

 

In its motion for summary judgment, Safa argues that the invoice is a valid contract, and accuses Perfect Wholesale of breach. Safa further alleges that it has suffered damages due to Perfect Wholesale's failure to make payment.

 

In response, Perfect Wholesale argued that the invoices were not contracts and Safa failed to fulfill its obligations. They claimed that Safa did not actually place orders for some of the products as claimed, and that the prices or deliveries of other products ordered were not accurate.

 

Perfect Wholesale has proposed a motion to revoke the inclusion of an evidence display in Safa's response to Perfect Wholesale's objections. They claim that the documents in the display were concealed by Safa during the discovery process, are unverified, and should not be submitted as evidence at this time.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | 5ml/2ml Dual Versions, Up to 45W Output: VAPORESSO Launches LUXE X3 on Official Website
Product | 5ml/2ml Dual Versions, Up to 45W Output: VAPORESSO Launches LUXE X3 on Official Website
VAPORESSO has listed the LUXE X3, a new addition to its LUXE X series, on its official website. The device features a 2,600mAh built-in battery, adjustable 5–45W output and a 0.8-inch digital display, and comes with a 5ml pod (2ml for the TPD version). The LUXE X3 has also appeared on some UK and US online retailers for pre-order, with prices below the company’s stated MSRP of $37.9.
Jan.19 by 2FIRSTS.ai
Malaysian Langkawi marine police seize vape devices and e-liquid worth US$43,902
Malaysian Langkawi marine police seize vape devices and e-liquid worth US$43,902
In Langkawi, Malaysia, the Marine Police seized various vape devices and e-liquid valued at RM178,400 (about US$43,902.99). Authorities believe the goods were intended to be smuggled out to a neighboring country.
Jan.15 by 2FIRSTS.ai
France’s ANSES warns vaping carries health risks, urges limiting e-cigarette use to smoking cessation
France’s ANSES warns vaping carries health risks, urges limiting e-cigarette use to smoking cessation
France’s National Agency for Food, Environmental and Occupational Health & Safety (ANSES) says vaping poses health risks because users inhale toxic or harmful substances, even if e-cigarettes are generally considered less harmful than cigarettes.
Feb.04 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
PMI Flags 2026 Headwinds from Japan Taxes, Sees Smoke-Free Growth Re-Accelerating Beyond in Earnings Call
PMI Flags 2026 Headwinds from Japan Taxes, Sees Smoke-Free Growth Re-Accelerating Beyond in Earnings Call
PMI said on its latest earnings call that Japan’s tax cycle will weigh on 2026 performance, while smoke-free growth is expected to re-accelerate thereafter. The discussion also covered U.S. regulation, ZYN strategy and AI-driven efficiency.
Feb.07
Walgreens Brings Vapes Back to Some U.S. Stores; Juul Says It’s in or Near 6,000 Locations
Walgreens Brings Vapes Back to Some U.S. Stores; Juul Says It’s in or Near 6,000 Locations
Walgreens has begun selling vape products again in some U.S. stores, marking a notable reversal after the chain pulled vapes from shelves in 2019 amid concerns over youth use and health risks. Juul says it is expanding across thousands of Walgreens locations, and NJOY also lists Walgreens stores as retailers.
Jan.26 by 2FIRSTS.ai